Quintiles

Home >
Browse Information Library >
Challenges in Conducting Trials in Alzheimer's Disease >
Access Protected Content

Request Access to Protected Content

Please fill out the form below to request access to “Challenges in Conducting Trials in Alzheimer's Disease.”

Fields marked with * are required.

Email Address:*

First Name:*

Last Name:*

Job Title:*

Function:*

Hold down "Control", or "Command" on a Mac, to select more than one.

Company:*

Country:*

Therapy Area:*

Hold down "Control", or "Command" on a Mac, to select more than one.

Please enter the text shown in the image:*

White Paper

Navigating Future Challenges in Alzheimer's Disease Trials

Quintiles’ own Alzheimer’s experts, Amir Kalali, Roza Hayduk and Lynne Hughes, sum up the insights and discoveries that could lead to the next breakthrough for Alzheimer’s disease.

Advancing Innovation

Prescreening and safety measures simplified a Phase II study of a four-dose vaccine that required multiple rating scales.

Learn more

Case Study

Anticipating the Challenge

Extensive experience and expertise in Alzheimer's Disease accelerated outcomes in multi-country Phase II study.

Learn more

Case Study

Alzheimer's Inroads

A global, multi-site Phase III trial required a large number of patients with a specific number of sites and patients at each site.

Learn more